header
Image from OpenLibrary

Study on microemulsion in some ocular delivery systems of certain ocular hypotensive drugs / Heba Muneer Mohammed Elsorogy ; Supervised Nadia Mohammed Morsi , Magdy Ibrahim Mohammed , Hanan Kamal Refai

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Heba Muneer Mohamed Elsorogy , 2016Description: 267 P. : charts , facsimiles ; 25cmOther title:
  • {uFEA9}{uFEAD}{uFE8D}{uFEB3}{uFE94} {uFECB}{uFEE0}{uFEF0} {uFE8D}{uFEDF}{uFEE3}{uFEB3}{uFE97}{uFEA3}{uFEE0}{uFE91}{uFE8E}{uFE95} {uFE8D}{uFEDF}{uFEA9}{uFED7}{uFEF3}{uFED8}{uFE94} {uFEDB}{uFE84}{uFEE7}{uFEC5}{uFEE3}{uFE94} {uFECB}{uFEFC}{uFE9F}{uFEF3}{uFE94} {uFEDF}{uFE91}{uFECC}{uFEBD} {uFE8D}{uFEF7}{uFEA9}{uFEED}{uFEF3}{uFE94} {uFE8D}{uFEDF}{uFEE3}{uFEA7}{uFED4}{uFEBF}{uFE94} {uFEDF}{uFEBF}{uFED0}{uFEC1} {uFE8D}{uFEDF}{uFECC}{uFEF3}{uFEE5} [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics Summary: Glaucoma, one of the leading causes of irreversible blindness in the world, is estimated to be suffered by 70 million people. Glaucoma is an ophthalmic disorder characterized by an increase in intraocular pressure, which results in a damage to the ganglion cells and the optic nerve and visual field disturbances. Intraocular pressure (IOP) is a function of production of liquid aqueous humor by the ciliary processes of the eye, and its drainage through the trabecular meshwork. The modern goal of glaucoma management is to avoid damage of the optic nerve by the raised intraocular pressure to preserve visual field and total quality of life for patients with minimal side effects. Agents used to treat glaucoma are designed to decrease intraocular pressure.These drugs limit aqueous humor production in the ciliary body and / or enhance aqueous outflow through the trabecular meshwork or the uveoscleral pathway. Carbonic anhydrase inhibitors are amongst the most powerful agents to lower IOP. They lower secretion of aqueous humor by inhibiting carbonic anhydrase in the ciliary body
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.Ph.D.2016.He.S (Browse shelf(Opens below)) Not for loan 01010110069198000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.Ph.D.2016.He.S (Browse shelf(Opens below)) 69198.CD Not for loan 01020110069198000

Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics

Glaucoma, one of the leading causes of irreversible blindness in the world, is estimated to be suffered by 70 million people. Glaucoma is an ophthalmic disorder characterized by an increase in intraocular pressure, which results in a damage to the ganglion cells and the optic nerve and visual field disturbances. Intraocular pressure (IOP) is a function of production of liquid aqueous humor by the ciliary processes of the eye, and its drainage through the trabecular meshwork. The modern goal of glaucoma management is to avoid damage of the optic nerve by the raised intraocular pressure to preserve visual field and total quality of life for patients with minimal side effects. Agents used to treat glaucoma are designed to decrease intraocular pressure.These drugs limit aqueous humor production in the ciliary body and / or enhance aqueous outflow through the trabecular meshwork or the uveoscleral pathway. Carbonic anhydrase inhibitors are amongst the most powerful agents to lower IOP. They lower secretion of aqueous humor by inhibiting carbonic anhydrase in the ciliary body

Issued also as CD

There are no comments on this title.

to post a comment.